Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125483161 | 12548316 | 1 | I | 0 | 20160711 | 20160711 | DIR | 0.00 | M | N | 0.00000 | 20160708 | N | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125483161 | 12548316 | 1 | PS | METFORMIN | METFORMIN HYDROCHLORIDE | 1 | 0 | ||||||||||||
125483161 | 12548316 | 2 | SS | INVOKANA | CANAGLIFLOZIN | 1 | 0 | ||||||||||||
125483161 | 12548316 | 3 | SS | TRADJENTA | LINAGLIPTIN | 1 | 0 | ||||||||||||
125483161 | 12548316 | 4 | SS | GLIPIZIDE. | GLIPIZIDE | 1 | 0 |
Indications of drugs used
no results found |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125483161 | 12548316 | Hypersensitivity | |
125483161 | 12548316 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |